Osteoarthritis in Canines: Joint Biomechanics and Management

Canine osteoarthritis (OA) is a progressive, degenerative joint disease characterized by the breakdown of articular cartilage, subchondral bone sclerosis, and the formation of osteophytes. It is often initiated by biomechanical instability, such as cranial cruciate ligament rupture or hip dysplasia, which alters the normal distribution of mechanical forces across the joint surface. This abnormal loading triggers an inflammatory cascade mediated by cytokines like interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-alpha), leading to the upregulation of matrix metalloproteinases (MMPs) that degrade the cartilage matrix. Management of OA requires a multimodal approach involving weight control to reduce mechanical stress, non-steroidal anti-inflammatory drugs (NSAIDs) to block cyclooxygenase (COX) pathways, physical rehabilitation, and potentially joint supplements like omega-3 fatty acids (EPA and DHA) which modulate the inflammatory response.